Barbara Fingleton

Matrix Metalloproteinases: Biologic Activity and Clinical Implications

Amy R. Nelson, Barbara Fingleton, Mace L. Rothenberg et al. · Journal of Clinical Oncology · 2000 · 1.5K citations

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Yang Li, Laura M. DeBusk, Koari Fukuda et al. · Cancer Cell · 2004 · 1.1K citations · Full text

Tumor Biology, Tumor-bearing Host, Cancer Immunosurveillance +8

Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1

Veerle Noë, Barbara Fingleton, Kathleen Jacobs et al. · Journal of Cell Science · 2001 · 688 citations

The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

Howard C. Crawford, Barbara Fingleton, Laura A. Rudolph‐Owen et al. · Oncogene · 1999 · 670 citations

Tumor Biology, Gastrointestinal Oncology, Medicine +9

The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis

William C. Powell, Barbara Fingleton, Carole L. Wilson et al. · Current Biology · 1999 · 421 citations · Full text

Protein Function, Biochemistry, Natural Sciences +11